13F Data
13F filer · CIK 1990716

TRV GP VI, LLC

Boston, MA · filing since Q4 2024 · last filing Aug 10, 2026
Reported value
$232.3M
+$96.7M vs prior
Positions
4
New / sold out
1 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $44.8M · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewSEAPORT THEREAPEUTICS, INC.+2,061,222–+$44.8M

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $116.9MQ1 2025: $42.0MQ2 2025: $64.2MQ3 2025: $109.6MQ4 2025: $148.5MQ1 2026: $135.6MQ2 2026: $232.3M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SEPTERNA, INC.COM4,211,659$141.0M60.72%
2SEAPORT THEREAPEUTICS, INC.COM2,061,222$44.8M19.27%
3RAPPORT THERAPEUTICS, INC.COM969,218$40.4M17.39%
4TANGO THERAPEUTICS, INC.COM194,174$6.1M2.61%